Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

High Intake of Illegal Drugs, Particularly amongst the Young Generation to Bolster Growth of the Global Drugs of Abuse Testing Market, Low-income Countries to Offer Plentiful Growth Opportunities for the Market Participants, TMR

This image opens in the lightbox

News provided by

Transparency Market Research

22 Mar, 2021, 15:30 GMT

Share this article

Share toX

Share this article

Share toX

- Illegal intake of drug is predominantly an adolescent phenomenon, growing exponentially through puberty and peaking in people aged between 18 years to 25 years

- Governments around the world have raised funding on law enforcement agencies tasked with drug interdiction, including compulsory drug testing of suspected illegal drug users

ALBANY, N.Y., March 22, 2021 /PRNewswire/ -- The global drugs of abuse testing market has grown rapidly due to a rise in the intake of illicit drugs and alcohol. The industry is also being influenced by a surge in government efforts to track and combat drug abuse. As per data from the United Nations Office on Drugs and Crime (UNODC), approximately 35 million people worldwide needed treatment for substance dependence in 2019. Opioids are linked to 55 percent of drug use disorders, whilst also marijuana is linked to 25%. According to UNODC data, there were 188 million cannabis consumers around the world in 2017. According to the National Center for Drug Abuse Statistics (NCDAS), about 1.5% to 5% of illnesses are caused directly by the use of illicit substances or addiction to alcohol. Such high prevalence of drug abuse is estimated to support development of the global drugs of abuse testing market in the years to come.

People suffering from substance use disorders have limited access to and availability of services around the world, with only one out of every seven cases are being treated every year. In advanced countries, such as the US, however, a favourable framework for reimbursement for treatment services has resulted in a greater demand for treatments of substance abuse. The Centers for Medicare & Medicaid Services (CMS) decided to expand its medicare coverage to include Medication-assisted Treatment (MAT) in opioid treatment programmes.

Request for Analysis of COVID-19 Impact on Drugs of Abuse Testing Market – https://www.transparencymarketresearch.com/covid19.php

The global drugs of abuse testing market was valued around US$ 4.6 Bn in 2018 and is expected to rise at 5.7 % CAGR over the forecast timeframe, from 2019 to 2027. Illegal drug use is predominantly an adolescent phenomenon, steadily growing through puberty and peaking in people aged between 18 to 25 years. Alcohol and drug abuse have detrimental societal impacts and put a huge burden on the health-care systems and workplace.

Key Findings of Market Report

  • High Misuse of Prescription Drugs amongst Young Generation to Accelerate Market Growth

The high prevalence and death rates in the US have made nonmedical use of prescription drugs and prescription drug misuse a major public health issue. According to the National Institute on Drug Abuse (NIDA), about 52 million individuals have utilized prescription drugs for various non-medical purposes at least once in their lives. OxyContin and Vicodin, both pain relievers, are the most widely misused prescription medications by young people. The high prevalence of comorbid diseases is also to blame for erroneous prescriptions and prescription drug abuse amongst the elderly.

Request Brochure of Drugs of Abuse Testing Market Report - https://www.transparencymarketresearch.com/brochure.php

The global drugs of abuse testing market is anticipated to rise as prescription drug abuse continues to climb. Individuals who use illegal drugs are somewhat more likely to be involved in a workplace accident, miss work more often, be less active, and change jobs. As a result, a number of employers place a high value on ensuring that their employees are drug-free via routine drug checks. Over the prediction timeframe, this factor is expected to raise the demand for drug dependency testing from both public and private employers. 

  • Developing Countries to Offer Plethora of Opportunities for the Market Participants

The consumption of illegal drugs has risen in the developing countries of Africa, Latin America, and Asia Pacific due to insufficient social support, poverty, and a lack of awareness. As a result, the global drugs of abuse testing market is projected to develop over time in these territories. According to the World Health Organization, 77 % of Brazilian children drink alcohol on a daily basis. Furthermore, intensive marketing and promotion of tobacco and alcohol are common in low-income countries. Expansion of the global drugs of abuse testing market in low-income and developed countries is anticipated to be hampered by insufficient infrastructure for providing drug testing services, limited awareness, and widespread availability of illegal drugs.

Purchase the Drugs of Abuse Testing Market Report - https://www.transparencymarketresearch.com/checkout.php

Drugs of Abuse Testing Market: Growth Drivers

  • Governments around the world have augmented spending on law enforcement agencies to fight drug trafficking by enforcing compulsory screening of suspected illegal drug consumers.
  • Owing to the increasing price of lab-based screening tests, as well as the capital and expertise needed to transport samples from the site of collection to the lab, a move towards on-the-spot testing has emerged.
  • In developing and low-income countries, insufficient infrastructure for delivering drug testing services, dearth of knowledge, and easy availability of illegal drugs are expected to stifle the development of the global drugs of abuse testing market.

Request for Custom Research - https://www.transparencymarketresearch.com/custom-research.php

Global Drugs of Abuse Testing Market: Key Competitors

  • Laboratory Corporation of America Holdings
  • Express Diagnostics International Inc.
  • Drägerwerk AG & Co. KGaA
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Allergic Rhinitis Drugs Market: https://www.transparencymarketresearch.com/allergic-rhinitis-drugs-market.html

Large Molecule Injectable Drugs Market: https://www.transparencymarketresearch.com/large-molecule-injectable-drugs-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/drugs-of-abuse-testing-market-2018-2026.htm 
Website: https://www.transparencymarketresearch.com/

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg 

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.